We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Bayer Aktiengesellschaft (PK) | USOTC:BAYRY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.015 | 0.20% | 7.37 | 1,742,657 | 20:59:55 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 7.35 | 7.39 | 7.40 | 7.27 | 7.29 | |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 21:06:06 | formt | 411 | 7.37 | USD |
| Date | Time | Source | Headline |
|---|---|---|---|
| 22/1/2024 | 14:26 | DJN | Bayer Names Nelson Ambrogio as New Head of Radiology Business |
| 08/1/2024 | 08:05 | DJN | Bayer's Menopause Drug Elinzanetant Met Primary Endpoints in Phase 3.. |
| 19/12/2023 | 10:12 | DJN | Bayer's Monsanto Ordered to Pay $857 Million Over Chemicals in Washington.. |
| 20/11/2023 | 15:43 | DJN | Trending: Bayer Shares Tank After Key Clinical Trial Halted Early, Roundup.. |
| 20/11/2023 | 10:20 | DJN | Bayer Shares Tumble After Clinical Trial Failure, Roundup Case Loss |
| 20/11/2023 | 07:22 | DJN | Bayer Stops Late-Stage Study for Stroke Prevention Due to Lack of Efficacy |
| 13/11/2023 | 15:58 | DJN | Bayer Pulling Lymphoma Drug Aliqopa From U.S. |
| 10/11/2023 | 15:00 | DJN | Bayer Gets CHMP Backing for Higher-Dose Eylea in Two Major Retinal Eye.. |
| 08/11/2023 | 10:32 | DJN | Bayer Weighs Structural Changes But Rules Out Three-Way Split -- 3rd Update |
| 08/11/2023 | 08:40 | DJN | Bayer Weighs Structural Changes But Rules Out Three-Way Split -- 2nd Update |
Bayer Aktiengesellschaft (PK) (BAYRY) Charts1 Year Bayer Aktiengesellschaft (PK) Chart |
|
1 Month Bayer Aktiengesellschaft (PK) Chart |
Intraday Bayer Aktiengesellschaft (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
